Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/32700
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVilloslada, Pablo
dc.contributor.authorAlonso, Cristina
dc.contributor.authorAgirrezabal, Ion
dc.contributor.authorKotelnikova, Ekaterina
dc.contributor.authorZubizarreta, Irati
dc.contributor.authorPulido-Valdeolivas, Irene
dc.contributor.authorSaiz, Albert
dc.contributor.authorComabella, Manuel
dc.contributor.authorMontalban, Xavier
dc.contributor.authorVillar, Luisa
dc.contributor.authorAlvarez-Cermeño, Jose Carlos
dc.contributor.authorFernández, Oscar
dc.contributor.authorAlvarez-Lafuente, Roberto
dc.contributor.authorArroyo, Rafael
dc.contributor.authorCastro, Azucena
dc.date.accessioned2019-06-28T17:06:54Z-
dc.date.available2019-06-28T17:06:54Z-
dc.date.issued2017-03
dc.identifier.citationNeurol Neuroimmunol Neuroinflamm.2017 Mar;(4)2:e321
dc.identifier.issn2332-7812
dc.identifier.urihttps://hdl.handle.net/20.500.12530/32700-
dc.description.abstractTo identify differences in the metabolomic profile in the serum of patients with multiple sclerosis (MS) compared to controls and to identify biomarkers of disease severity.
dc.language.isoeng
dc.rightsopenAccess-
dc.titleMetabolomic signatures associated with disease severity in multiple sclerosis.
dc.typeArtículo
dc.identifier.pubmedID28180139
dc.format.volume4
dc.format.pagee321
dc.identifier.journalNeurology(R) neuroimmunology & neuroinflammation
dc.identifier.doi10.1212/NXI.0000000000000321
dc.format.number2
dc.identifier.pmcPMC5278923
dc.pubmedtypeJournal Article
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos

Files in This Item:
File Description SizeFormat 
PMC5278923.pdf821.22 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.